DeLarme Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
DeLarme Wealth Management's LLY Position: Q3 2026 in Review
DeLarme Wealth Management increased its Eli Lilly (LLY) stake by 0.56% in Q3 2026, buying an estimated $1.18K and bringing the position to 180 shares worth $208K. The position accounts for 0.12% of the portfolio, ranked #71.
DeLarme Wealth Management first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. The position peaked at $215K in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- DeLarme Wealth Management held 180 shares of Eli Lilly worth $208K as of Q3 2026.
- DeLarme Wealth Management bought 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
- Eli Lilly made up 0.12% of DeLarme Wealth Management's portfolio in Q3 2026, its #71 holding.
- DeLarme Wealth Management first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
- DeLarme Wealth Management's Eli Lilly position peaked at $215K in Q2 2026.
- 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on DeLarme Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.